鹏华国证疫苗与生物科技ETF(159657)资产负债表
| |
2025-06-30 |
2024-12-31 |
2024-06-30 |
2023-12-31 |
| 资产 |
| 银行存款 |
- |
- |
- |
- |
| 结算备付金 |
226,974.93 |
39,449.03 |
75,558.39 |
139,524.92 |
| 存出保证金 |
251,222.58 |
42,081.36 |
40,165.86 |
109,425.03 |
| 交易性金融资产 |
113,722,587.57 |
130,264,095.62 |
127,837,125.09 |
206,737,326.52 |
| 其中：股票投资 |
113,722,587.57 |
130,264,095.62 |
127,837,125.09 |
206,737,326.52 |
| 债券投资 |
- |
- |
- |
- |
| 资产支持证券投资 |
- |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
- |
| 应收证券清算款 |
- |
5,860.05 |
- |
71,798.10 |
| 应收利息 |
- |
- |
- |
- |
| 应收股利 |
- |
- |
- |
- |
| 应收申购款 |
- |
- |
- |
- |
| 其他资产 |
75,616.24 |
4,378.81 |
75,410.10 |
5,168.38 |
| 资产总计 |
115,892,092.67 |
131,974,251.74 |
130,045,788.43 |
209,894,288.76 |
| 负 债 |
| 短期借款 |
- |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
- |
| 应付证券清算款 |
2,770.67 |
141,317.43 |
- |
14,611.78 |
| 应付赎回款 |
- |
- |
- |
- |
| 应付管理人报酬 |
47,272.81 |
58,310.68 |
56,744.84 |
90,729.27 |
| 应付托管费 |
9,454.58 |
11,662.14 |
11,348.98 |
18,145.87 |
| 应付销售服务费 |
- |
- |
- |
- |
| 应付交易费用 |
- |
- |
- |
- |
| 应交税费 |
- |
- |
- |
751.39 |
| 应付利息 |
- |
- |
- |
- |
| 应付利润 |
- |
- |
- |
- |
| 其他负债 |
163,554.43 |
229,881.23 |
175,476.47 |
634,999.95 |
| 负债合计 |
223,052.49 |
441,171.48 |
243,570.29 |
759,238.26 |
| 所有者权益 |
| 实收基金 |
183,514,819.00 |
205,514,819.00 |
218,514,819.00 |
245,514,819.00 |
| 未分配利润 |
-67,845,778.82 |
-73,981,738.74 |
-88,712,600.86 |
-36,379,768.50 |
| 所有者权益合计 |
115,669,040.18 |
131,533,080.26 |
129,802,218.14 |
209,135,050.50 |
| 负债及所有者权益总计 |
115,892,092.67 |
131,974,251.74 |
130,045,788.43 |
209,894,288.76 |
微信公众号
证券之星APP
基本资料
